Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
Clinical trial NCT06069843 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06069843
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2025-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.